Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pharynx01:20

Pharynx

The pharynx, a tubular structure framed by skeletal muscle and lined with mucous membrane, extends continuously from the nasal cavities. It is segmented into three major areas: the nasopharynx, oropharynx, and laryngopharynx.
Nasopharynx
The nasopharynx, bordered by the conchae of the nasal cavity, serves exclusively as an air conduit. In its superior region, the pharyngeal tonsils or adenoids are located. These tonsils are clusters of lymphoid reticular tissue akin to a lymph node. The precise...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

AJNR. American journal of neuroradiology·2020
Same author

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?

Clinical oncology (Royal College of Radiologists (Great Britain))·2018

Related Experiment Videos

Nasopharyngeal carcinoma.

A T C Chan1

  • 1State Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong. anthony@clo.cuhk.edu.hk

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|October 15, 2010
PubMed
Summary

Distant metastases are the main failure for nasopharyngeal carcinoma despite improved radiotherapy. Current treatments include cisplatin-radiotherapy, with neoadjuvant chemotherapy showing promise. Epstein-Barr virus (EBV) DNA monitoring is valuable for patient management.

Related Experiment Videos

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Virology

Background:

  • Nasopharyngeal carcinoma (NPC) management has evolved with advanced imaging and radiotherapy, improving local control.
  • Distant metastasis has emerged as the primary cause of treatment failure in NPC patients.
  • Current standard treatment for Stage IIB and above NPC involves concurrent cisplatin-radiotherapy, potentially with adjuvant chemotherapy.

Purpose of the Study:

  • To review the current treatment strategies for nasopharyngeal carcinoma.
  • To highlight the evolving role of neoadjuvant chemotherapy and novel therapeutic approaches.
  • To discuss the clinical utility of quantitative Epstein-Barr virus (EBV) DNA in NPC management.

Main Methods:

  • Review of current literature on nasopharyngeal carcinoma treatment and management.
  • Analysis of standard treatment protocols, including concurrent chemoradiotherapy and adjuvant chemotherapy.
  • Evaluation of emerging therapies such as neoadjuvant chemotherapy, targeted agents, and immunotherapy.

Main Results:

  • Improved local control in NPC has shifted the focus to managing distant metastases.
  • Neoadjuvant chemotherapy is a promising strategy, with phase III trial results pending.
  • Quantitative Epstein-Barr virus (EBV) DNA shows clinical utility for disease monitoring and potential risk stratification.

Conclusions:

  • Nasopharyngeal carcinoma treatment is increasingly focused on preventing distant metastases.
  • Neoadjuvant chemotherapy and novel targeted/immunotherapies represent future directions in NPC treatment.
  • Quantitative EBV DNA monitoring offers valuable insights for patient follow-up and personalized treatment strategies.